ONCOLYTICS BIOTECH INCORPORATED (OTCMKTS:ONCYF) had a decrease of 2.42% in short interest. ONCYF’s SI was 301,900 shares in January as released by FINRA. Its down 2.42% from 309,400 shares previously. With 695,500 avg volume, 0 days are for ONCOLYTICS BIOTECH INCORPORATED (OTCMKTS:ONCYF)’s short sellers to cover ONCYF’s short positions. The stock increased 6.25% or $0.0349 during the last trading session, reaching $0.5924. About shares traded. Oncolytics Biotech Inc. (OTCMKTS:ONCYF) has 0.00% since January 4, 2017 and is . It has underperformed by 16.70% the S&P500.
Fulton Bank increased Cummins Inc (CMI) stake by 35.6% reported in 2017Q3 SEC filing. Fulton Bank acquired 2,322 shares as Cummins Inc (CMI)’s stock rose 1.30%. The Fulton Bank holds 8,845 shares with $1.49 million value, up from 6,523 last quarter. Cummins Inc now has $29.71 billion valuation. The stock increased 1.10% or $1.95 during the last trading session, reaching $179.01. About 932,839 shares traded. Cummins Inc. (NYSE:CMI) has risen 43.32% since January 4, 2017 and is uptrending. It has outperformed by 26.62% the S&P500.
Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancers. The company has market cap of $86.58 million. The firm is developing REOLYSIN, a systemically administered immune-oncology viral agent for the treatment of solid tumors and hematological malignancies. It currently has negative earnings.
Among 28 analysts covering Cummins (NYSE:CMI), 7 have Buy rating, 3 Sell and 18 Hold. Therefore 25% are positive. Cummins has $20000 highest and $79 lowest target. $153.13’s average target is -14.46% below currents $179.01 stock price. Cummins had 91 analyst reports since July 22, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Thursday, July 14 by Standpoint Research. RBC Capital Markets maintained it with “Hold” rating and $168.0 target in Tuesday, October 10 report. Jefferies maintained Cummins Inc. (NYSE:CMI) rating on Thursday, September 1. Jefferies has “Hold” rating and $120 target. The rating was maintained by Wells Fargo on Friday, October 6 with “Market Perform”. The company was maintained on Friday, October 20 by Jefferies. The stock has “Buy” rating by Buckingham Research on Wednesday, November 1. As per Monday, April 18, the company rating was upgraded by Bank of America. Barclays Capital upgraded the shares of CMI in report on Monday, January 9 to “Equal Weight” rating. The firm earned “Underweight” rating on Friday, September 25 by Barclays Capital. The firm has “Neutral” rating given on Friday, May 13 by Citigroup.
Fulton Bank decreased Nuveen Invt Inc stake by 16,355 shares to 56,708 valued at $1.46 million in 2017Q3. It also reduced Mcdonalds Corp (NYSE:MCD) stake by 9,171 shares and now owns 42,690 shares. Undiscovered Managers Fds (UBVLX) was reduced too.